Cantor Fitzgerald Reiterates Overweight on Core Scientific, Maintains $20 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Brett Knoblauch has reiterated an Overweight rating on Core Scientific (NASDAQ:CORZ) and maintained a $20 price target.
August 08, 2024 | 3:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald analyst Brett Knoblauch has reiterated an Overweight rating on Core Scientific (NASDAQ:CORZ) and maintained a $20 price target.
The reiteration of an Overweight rating and a maintained price target of $20 by a reputable analyst can boost investor confidence in Core Scientific, potentially leading to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100